These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6756463)

  • 21. Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus.
    Shu S; Provost T; Croxdale MB; Reichlin M; Beutner EH
    Clin Exp Immunol; 1977 Feb; 27(2):238-44. PubMed ID: 300310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatology and diagnosis in connective tissue disease. II. Evaluations and follow-up examinations in consequence of a speckled antinuclear immunofluorescence pattern.
    Jonsson J; Norberg R
    Scand J Rheumatol; 1978; 7(4):229-36. PubMed ID: 366740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with arthritis and anti-U1-RNP antibodies: a 10-year follow-up.
    Piirainen HI
    Br J Rheumatol; 1990 Oct; 29(5):345-8. PubMed ID: 2224402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed connective tissue disease in children.
    Peskett SA; Ansell BM; Fizzman P; Howard A
    Rheumatol Rehabil; 1978 Nov; 17(4):245-8. PubMed ID: 310575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin G subclass distribution of autoantibodies in systemic sclerosis, primary biliary cirrhosis, and overlap syndromes.
    French MA; Bernstein RM
    Ann Rheum Dis; 1987 Jun; 46(6):436-40. PubMed ID: 3115201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.
    Fishbein E; Ramos-Niembro F; Alarcon-Segovia D
    J Rheumatol; 1978; 5(4):384-90. PubMed ID: 310882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro study of the binding of antiribonucleoprotein antibodies to the nucleus of isolated living keratinocytes.
    Galoppin L; Saurat JH
    J Invest Dermatol; 1981 Apr; 76(4):264-7. PubMed ID: 6162900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of speckled fluorescent antinuclear antibody test antisera using electrofocused nuclear antigens.
    Okarma TB; Krueger JA; Holman HR
    J Clin Invest; 1982 Aug; 70(2):296-303. PubMed ID: 6808026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical significance of the in vivo antinuclear antibody phenomenon.
    Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
    Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed connective tissue disease characterized by speckled epidermal nuclear IgG deposition in normal skin.
    Bentley-Phillips CB; Geake TM
    Br J Dermatol; 1980 May; 102(5):529-33. PubMed ID: 7387899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and laboratory findings in childhood mixed connective tissue disease: presence of antibody to ribonucleoprotein containing the small nuclear ribonucleic acid U1.
    Savouret JF; Chudwin DS; Wara DW; Ammann AJ; Cowan MJ; Miller WL
    J Pediatr; 1983 Jun; 102(6):841-6. PubMed ID: 6189985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of antinuclear matrix antibody in serum from patients with anti-U1RNP antibody.
    Sato S; Hasegawa M; Ihn H; Kikuchi K; Takehara K
    Arch Dermatol Res; 2000; 292(2-3):55-9. PubMed ID: 10749556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of antibody against extractable nuclear antigen by an enzyme-linked immuno-sorbent assay. Results from patients with rheumatic and internal medical diseases.
    Struckmann J; Worning P; Manthorpe R; Bendixen G
    Allergy; 1985 Aug; 40(6):442-6. PubMed ID: 3876784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed connective tissue disease (MCTD)--its immunological characteristics.
    Chorzelski T; Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):779-82. PubMed ID: 312087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
    Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear immunofluorescent patterns in mixed connective tissue disease (MCTD).
    Burnham TK
    J Am Acad Dermatol; 1981 Jan; 4(1):95-6. PubMed ID: 7009661
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidermal nuclear fluorescence.
    Iwatsuki K
    Br J Dermatol; 1983 Sep; 109(3):370. PubMed ID: 6604540
    [No Abstract]   [Full Text] [Related]  

  • 40. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.